Ivan King
8Patents
3h-index
11Co-inventors
46Inventor score
Filing activity: Aug 24, 2000 → May 27, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6962696B1 | Compositions and methods for tumor-targeted delivery of effector molecules | Emerging Cross-Sectional Technologies | 57 | Expired |
| US7452531B2 | Compositions and methods for tumor-targeted delivery of effector molecules | Emerging Cross-Sectional Technologies | 46 | Expired |
| US6855695B2 | Water-soluble SHPs as novel alkylating agents | Chemistry; Metallurgy | 12 | Expired |
| US7405317B2 | Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents | Chemistry; Metallurgy | 1 | Expired |
| US6911460B2 | Antiviral agents and methods of treating viral infections | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7605137B2 | Combination therapy comprising cloretazine | Human Necessities | 0 | Expired |
| US8026395B1 | Process for the synthesis of anti-neoplasia agent VNP40101M | Chemistry; Metallurgy | 0 | Active |
| US7273714B2 | Alkylguanyltransferase assays | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.